ClinicalTrials.Veeva

Menu

Effect of Myoinositol Treatment of Spermatozoa on in Vitro Fertilization Outcome (MI_ICSI)

A

AGUNCO Obstetrics and Gynecology Centre

Status

Completed

Conditions

Couple Sterility

Treatments

Other: untreated
Dietary Supplement: Myo-inositol

Study type

Interventional

Funder types

Other

Identifiers

NCT02050672
MI_ICSI

Details and patient eligibility

About

In the present trial, the investigators aim to evaluate whether semen myo-inositol (MI) treatment is able to improve IVF outcomes.

In particular, retrieved oocytes will be randomly divided in two groups, one group will be inseminated with MI treated semen while the other will be inseminated with untreated semen.

Full description

Myo is synthesized from glucose-6-phosphate, it is a precursor of second messengers in the cell signaling pathways and it is involved in the regulation of intracellular calcium.

Literature data have demonstrated the MI play a crucial role in reproduction, indeed, oocyte and spematozoa are nursed in a medium congaing hig MI concentration.

Furthermore, it has been demonstrated that, in oligoasthenoteratozoospermic patients, in vitro incubation with 2 mg/ml of myo increase significantly the number of spermatozoa with high mitochondrial membrane potential (MMP). Moreover, it has been found that the in vitro fertilization rate is correlated with the percentage of high MMP spermatozoa.

Enrollment

249 patients

Sex

Male

Ages

30 to 42 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • couple counselled for IVF

Exclusion criteria

  • cryopreserved sample

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

249 participants in 2 patient groups

untreated
Active Comparator group
Description:
Semen was prepared with routinely used media
Treatment:
Other: untreated
myo-inositol
Experimental group
Description:
routinely used semen preparation media have been enriched with myo-inositol 2mg/ml. in particular the stock solution was prepared in order to add 15microliters per ml of medium
Treatment:
Dietary Supplement: Myo-inositol

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems